BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34758497)

  • 1. Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes.
    Palatnik A; Harrison RK; Thakkar MY; Walker RJ; Egede LE
    Am J Perinatol; 2022 Jan; 39(1):8-15. PubMed ID: 34758497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing patterns in medication prescription for gestational diabetes during a time of guideline change in the USA: a cross-sectional study.
    Venkatesh KK; Chiang CW; Castillo WC; Battarbee AN; Donneyong M; Harper LM; Costantine M; Saade G; Werner EF; Boggess KA; Landon MB
    BJOG; 2022 Feb; 129(3):473-483. PubMed ID: 34605130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider-based initiation and management of pharmacologic therapy for gestational diabetes mellitus.
    Harrison RK; Johnson C; Cruz M; Wong A; Davitt C; Palatnik A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(23):4478-4484. PubMed ID: 33243048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.
    de Wit L; Rademaker D; Voormolen DN; Akerboom BMC; Kiewiet-Kemper RM; Soeters MR; Verwij-Didden MAL; Assouiki F; Schippers DH; Vermeulen MAR; Kuppens SMI; Oosterwerff MM; Zwart JJ; Diekman MJM; Vogelvang TE; Gallas PRJ; Galjaard S; Visser W; Horree N; Klooker TK; Laan R; Heijligenberg R; Huisjes AJM; van Bemmel T; van Meir CA; van den Beld AW; Hermes W; Vidarsdottir S; Veldhuis-Vlug AG; Dullemond RC; Jansen HJ; Sueters M; de Koning EJP; van Laar JOEH; Wouters-van Poppel P; Sanson-van Praag ME; van den Akker ES; Brouwer CB; Hermsen BB; Potter van Loon BJ; van der Heijden OWH; de Galan BE; van Leeuwen M; Wijbenga JAM; de Boer K; van Bon AC; van der Made FW; Eskes SA; Zandstra M; van Houtum WH; Braams-Lisman BAM; Daemen-Gubbels CRGM; Wouters MGAJ; IJzerman RG; Mensing van Charante NA; Zwertbroek R; Bosmans JE; Evers IM; Mol BW; de Valk HW; Groenendaal F; Naaktgeboren CA; Painter RC; deVries JH; Franx A; van Rijn BB
    BMJ Open; 2019 Aug; 9(8):e029808. PubMed ID: 31427334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis.
    Tarry-Adkins JL; Aiken CE; Ozanne SE
    PLoS Med; 2020 May; 17(5):e1003126. PubMed ID: 32442232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Priorities, Decisional Comfort, and Satisfaction with Metformin versus Insulin for the Treatment of Gestational Diabetes Mellitus.
    Venkatesh KK; Wu J; Trinh A; Cross S; Rice D; Powe CE; Brindle S; Andreatta S; Bartholomew A; MacPherson C; Costantine MM; Saade G; McAlearney AS; Grobman WA; Landon MB
    Am J Perinatol; 2024 May; 41(S 01):e3170-e3182. PubMed ID: 38049101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents: results of a prospective, randomised study.
    Zawiejska A; Wender-Ozegowska E; Grewling-Szmit K; Brazert M; Brazert J
    J Physiol Pharmacol; 2016 Apr; 67(2):227-33. PubMed ID: 27226182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population-based cohort study.
    Yu YH; Platt RW; Reynier P; Yu OHY; Filion KB
    Diabet Med; 2023 Aug; 40(8):e15108. PubMed ID: 37029772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
    Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus.
    Harrison RK; Cruz M; Wong A; Davitt C; Palatnik A
    BMC Pregnancy Childbirth; 2020 Dec; 20(1):773. PubMed ID: 33308193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis.
    Liang HL; Ma SJ; Xiao YN; Tan HZ
    Medicine (Baltimore); 2017 Sep; 96(38):e7939. PubMed ID: 28930827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials.
    Jiang YF; Chen XY; Ding T; Wang XF; Zhu ZN; Su SW
    J Clin Endocrinol Metab; 2015 May; 100(5):2071-80. PubMed ID: 25803270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of oral antidiabetic medications in gestational diabetes mellitus.
    Paglia MJ; Coustan DR
    Curr Diab Rep; 2009 Aug; 9(4):287-90. PubMed ID: 19640341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.
    Camelo Castillo W; Boggess K; Stürmer T; Brookhart MA; Benjamin DK; Jonsson Funk M
    Obstet Gynecol; 2014 Jun; 123(6):1177-1184. PubMed ID: 24807336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.
    Guo L; Ma J; Tang J; Hu D; Zhang W; Zhao X
    J Diabetes Res; 2019; 2019():9804708. PubMed ID: 31781670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin is comparable to insulin for pharmacotherapy in gestational diabetes mellitus: A network meta-analysis evaluating 6046 women.
    Musa OAH; Syed A; Mohamed AM; Chivese T; Clark J; Furuya-Kanamori L; Xu C; Toft E; Bashir M; Abou-Samra AB; Thalib L; Doi SA
    Pharmacol Res; 2021 May; 167():105546. PubMed ID: 33716167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review.
    Nicholson W; Bolen S; Witkop CT; Neale D; Wilson L; Bass E
    Obstet Gynecol; 2009 Jan; 113(1):193-205. PubMed ID: 19104375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Agents for the Treatment of Gestational Diabetes.
    Finneran MM; Landon MB
    Curr Diab Rep; 2018 Sep; 18(11):119. PubMed ID: 30267230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial.
    Reynolds RM; Denison FC; Juszczak E; Bell JL; Penneycard J; Strachan MWJ; Lindsay RS; Alexander CI; Love CDB; Whyte S; Mackenzie F; Stenson B; Norman JE
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):316. PubMed ID: 28938877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational diabetes mellitus management with oral hypoglycemic agents.
    Ryu RJ; Hays KE; Hebert MF
    Semin Perinatol; 2014 Dec; 38(8):508-15. PubMed ID: 25315294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.